Prevention of Organ Dysfunction and Mortality by Monitoring the Administration of Opioids and Hypnotics in Patients at High Postoperative Risk

Abroad (travel likely)Recruiting

Conditions

Sedation and Analgesia Monitoring

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Chu D'Amiens Picardie, Amiens, France

    Contact: Principal Investigator (Hervé DUPONT, MD PhD)
  • Clinique Victor Pauchet, Amiens, France

    Contact: Principal Investigator (Pierre HUETTE, MD)
  • Chru de Besancon, Besançon, France

    Contact: Principal Investigator (Guillaume BESCH, MD PhD)
  • Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France

    Contact: Principal Investigator (Philippe RICHEBE, MD, PhD)
  • Chu Clermont-Ferrand, Clermont-Ferrand, France

    Contact: Principal Investigator (Bertille PAQUETTE, MD)
  • Chu de Grenoble, Grenoble, France

    Contact: Principal Investigator (Pierre BOUZAT, MD PhD)
  • Chu de Lille, Lille, France

    Contact: Principal Investigator (Gilles LEBUFFE, MD PhD)
  • APHM - Centre Hôpital Marseille Nord, Marseille, France

    Contact: Principal Investigator (Marc LEONE, MD PhD)
  • Chu de Nantes, Nantes, France

    Contact: Principal Investigator (Raphaël CINOTTI, MD PhD)
  • Chu de Nimes, Nîmes, France

    Yann GRICOURT, MD (Sub-investigator)
    Contact: Principal Investigator (Philippe CUVILLON, MD PhD)
  • Hopital Bichat Claude Bernard, Paris, France

    Contact: Principal Investigator (Aurélie GOUEL, MD)
  • Chu Lyon Sud, Pierre-Bénite, France

    Contact: Principal Investigator (Arnaud FRIGGERI, MD, PhD)
  • Chu de Poitiers, Poitiers, France

    Contact: Principal Investigator (Matthieu BOISSON, MD)
  • Hôpital Saint Charles, Saint-Dié, France

    Contact: Principal Investigator (Claude MEISTELMAN, MD, PhD)
  • Chu St-Etienne, Saint-Etienne, France

    Serge MOLLIEX, MD, PhD (Sub-investigator)
    Contact: Principal Investigator (David CHARIER, MD, PhD)
  • Chu de Toulouse, Toulouse, France

    Contact: Principal Investigator (Fabrice FERRE, MD PhD)
  • Institut Gustave Roussy, Villejuif, France

    Contact: Principal Investigator (Cyrus MOTAMED, MD)
  • Médipole Lyon Villeurbanne, Villeurbanne, France

    Contact: Principal Investigator (Vincent COLLANGE, MD)
Study leads
  • David CHARIER, MD, PhD

    Principal Investigator

    CHU DE SAINT-ETIENNE